McKinley Kate reported RANI

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001979211-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 3, 2026

Published

Jun 5, 2026

Ingested by INSIDER

Nov 5, 03:54 UTC

Last re-read

Nov 5, 03:54 UTC

Extracted facts

Filer

McKinley Kate

Role

Chief Business Officer

Transaction

Grant or awardAs filed: “A”

Asset

Rani Therapeutics Holdings, Inc. — Stock Option (Right to Buy)

Ticker

RANI

Shares

805.5K

Price per share

$0

Execution date (reported)

Jun 3, 2026

Owned after transaction

805.5K shares

Days from execution to publication

2

What this establishes

McKinley Kate filed this Form 4 reporting a grant or award of RANI on Jun 3, 2026. It became public on Jun 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Business Officer

McKinley Katecik:0001979211

Issuer

Rani Therapeutics Holdings, Inc.cik:0001856725

Revision history · 0

No field has changed since this record was first ingested.